Mergers and Acquisition in MedTech in 2021
The medical device (MedTech) industry has small and big companies operating in various segments such as cardiovascular, renal care, and diabetes management, among others. It has been witnessed that the small companies or start-up companies that work in developing new promising products are often acquired by one of the large medical device companies, benefiting both parties. This is because small companies can face the challenge to market the device, whereas major companies have established distribution networks and relationships with hospitals and other providers. Large companies can also provide funds for further research and development needed for advancements of devices.
Through this whitepaper, DelveInsight is representing the current scenario of mergers and acquisitions in the medical device industry in the last year along with the data of the first half of 2021. The whitepaper includes an introduction, mergers, and acquisitions in MedTech, deals in 2021, and a conclusion. The reason for M&A can be geographic expansion, portfolio optimization, cross-selling initiatives, among others. During the COVID-19 pandemic, even though there was an increase in the demand for protective equipment, ventilator hardware, and diagnostic tests, the medical device industry witnessed a halt in the circulation of the devices, which slowed down the rate of MedTech mergers and acquisitions deals. Irrespective of this, 2021 has had the strongest first quarter for medical device companies since 2016, and many deals are expected in the year as well. The total deal worth USD 31.5 billion took place in the first six months of 2021. The whitepaper provides details of the deal that took place in 2021 and the effects of COVID-19 on the industry.
Follow our blog series to get more insights on: